iRhythm Holdings, Inc. filings document the public-company reporting of a digital health care business centered on ambulatory cardiac monitoring. Recent Form 8-K disclosures report operating results, financial condition, guidance-related exhibits, Regulation FD materials, material agreements, executive compensation policy changes, board appointments, and changes in the independent registered public accounting firm.
Proxy materials cover director elections, board and committee structure, executive compensation, equity awards, and stockholder voting matters. The filing record also documents the completed holding-company reorganization under which iRhythm Holdings became successor registrant to iRhythm Technologies, including common-stock continuity and predecessor registration-termination records.
Form 3/A overview: iRhythm Technologies, Inc. (IRTC) filed an amended Form 3 for newly appointed Chief Technology Officer Brian Lee Lawrence. The amendment, dated 06/27/2025, corrects the original 04/21/2025 filing by attaching the Power of Attorney that was previously omitted.
Key points for investors:
- No securities owned: The report states that Mr. Lawrence currently holds zero shares or derivative securities of IRTC.
- Administrative nature: No changes to capital structure, operations, or financial outlook are disclosed; the sole purpose is to provide the missing document.
- Insider alignment: The absence of ownership may indicate limited immediate equity alignment between the CTO and shareholders, although incentive grants can follow after employment begins.
This filing is largely procedural and does not contain material financial information or signal any strategic shift for iRhythm.